Medline Inc. vs Abbvie Inc.
MDLN vs ABBV — side-by-side comparison from reported financials. MDLN leads 3, ABBV leads 7 of 10 comparable metrics.
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | MDLN | ABBV |
|---|---|---|
| Price | $36.29 | $276.43 |
| Market cap | $31.8B | $488B |
| Revenue (TTM) | $29.9B | $64.4B |
| Revenue growth | +9.8% | +1.8% |
| Net margin | 1.7% | 9.8% |
| Free cash flow | $1.58B | $18.2B |
| Net cash (debt) | ($10.6B) | ($56.2B) |
| 1-year price return | — | +19.8% |
| P/E | 68.8 | 77.4 |
| P/E vs own history (cheap-side %) | 15% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 5% | 96% |
| Altman Z-score | 1.65 | 2.33 |
| CV checks passed | 5 of 10 | 9 of 10 |
| Employees | 45,000 | 57,000 |
Full résumé-style profiles: MDLN CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.